E-LIB Suche - Ergebnisse für: Sommerburg, O.

1

WS11.03 Early cystic fibrosis lung disease in the TRACK-CF ..:

Steinke, E. ; Wielpütz, M.O. ; Schnorr, A.N....
Journal of Cystic Fibrosis. 23 (2024) - p. S20-S21 , 2024

Link: https://doi.org/10.1016/..

2

Cystic fibrosis—When the diagnosis remains uncertain; Mukov..:

Hammermann, J. ; Ballmann, M. ; Bend, J....
Monatsschrift Kinderheilkunde. 172 (2024) 6 - p. 510-518 , 2024

Link: https://doi.org/10.1007/..

3

Chronic rhinosinusitis in people with cystic fibrosis—an up..:

Yılmaz Topçuoğlu, M. ; Sommerburg, O. ; Wielpütz, M. O....
HNO. , 2024

Link: https://doi.org/10.1007/..

4

P360 CFTR modulator therapy with elexacaftor/tezacaftor/iva..:

Chung, J. ; Hämmerling, S. ; Hirtz, S....
Journal of Cystic Fibrosis. 23 (2024) - p. S178 , 2024

Link: https://doi.org/10.1016/..

5

111 Long-term effects of lumacaftor-ivacaftor on chronic rh..:

Wucherpfennig, L. ; Wuennemann, F. ; Eichinger, M....
Journal of Cystic Fibrosis. 22 (2023) - p. S58-S59 , 2023

Link: https://doi.org/10.1016/..

6

121 Longitudinal MRI of morphological and perfusion abnorma..:

Wielputz, M. ; Triphan, S. ; Wucherpfennig, L....
Journal of Cystic Fibrosis. 22 (2023) - p. S63-S64 , 2023

Link: https://doi.org/10.1016/..

7

110 Elexacaftor-tezacaftor-ivacaftor improves bronchial art..:

Wucherpfennig, L. ; Triphan, S. ; Wege, S....
Journal of Cystic Fibrosis. 22 (2023) - p. S58 , 2023

Link: https://doi.org/10.1016/..

8

139 Comprehension of early cystic fibrosis lung disease or ..:

Steinke, E. ; Sommerburg, O. ; Graeber, S....
Journal of Cystic Fibrosis. 22 (2023) - p. S73-S74 , 2023

Link: https://doi.org/10.1016/..

9

184 Effects of elexacaftor/tezacaftor/ivacaftor therapy on ..:

Graeber, S. ; Renz, D. ; Stahl, M....
Journal of Cystic Fibrosis. 21 (2022) - p. S108 , 2022

Link: https://doi.org/10.1016/..

10

ePS5.09 Comparison of the Lung Clearance Index in preschool..:

Röhmel, J. ; Dörfler, F. ; Koerner-Rettberg, C....
Journal of Cystic Fibrosis. 21 (2022) - p. S58 , 2022

Link: https://doi.org/10.1016/..

11

WS06.04 Effects of elexacaftor/tezacaftor/ivacaftor therapy..:

Graeber, S.Y. ; Vitzthum, C. ; Pallenberg, S.T....
Journal of Cystic Fibrosis. 21 (2022) - p. S12 , 2022

Link: https://doi.org/10.1016/..

12

WS17.02 Long-term efficacy of lumacaftor/ivacaftor (LUM/IVA..:

Stahl, M. ; Roehmel, J. ; Eichinger, M....
Journal of Cystic Fibrosis. 21 (2022) - p. S32-S33 , 2022

Link: https://doi.org/10.1016/..

13

WS12.1 An exploratory study to determine the impact of luma..:

Stahl, M. ; Roehmel, J. ; Eichinger, M....
Journal of Cystic Fibrosis. 20 (2021) - p. S22-S23 , 2021

Link: https://doi.org/10.1016/..

14

WS06.1 Defining key outcomes to evaluate performance of new..:

Munck, A. ; Southern, K. ; Castellani, C....
Journal of Cystic Fibrosis. 20 (2021) - p. S11 , 2021

Link: https://doi.org/10.1016/..

15

Magnetresonanztomographie der Lunge bei Mukoviszidose:

Leutz-Schmidt, P. ; Eichinger, M. ; Sommerburg, O....
Der Radiologe. 60 (2020) 9 - p. 813-822 , 2020

Link: https://doi.org/10.1007/..